Working under the Ministry of Ayush, NMPB is mandated to coordinate all matters relating to medicinal plants and support policies and programs for growth of trade, export, conservation, and cultivation of medicinal plants
Investment in single-use endoscopes, digital solutions, and endoluminal therapies expected
The company plans to expand their capacity to meet the needs of pharma and biotech industries
Organised by the Indian Stroke Association, it has attracted over 800 doctors from India and overseas
It plans to add over 1000 employees over the next six months
This is the fourth facility from the company to receive this registration
Healtherbs helps in restoring the desired energy levels for daily activity and immunity
A Care network is a digital health network that connects healthcare stakeholders to deliver streamlined care with the patient at the centre of the experience
_256_384.jpg)
Ind-Ra expects IPM revenue growth of over 12% yoy for FY22.
The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.
Subscribe To Our Newsletter & Stay Updated
